Literature DB >> 25083532

Evidence for harm, comment on ‘Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study’.

Daniel F Kripke, Robert D Langer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25083532      PMCID: PMC4168393          DOI: 10.1111/bcp.12265

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study.

Authors:  Anton Pottegård; Søren Friis; Morten Andersen; Jesper Hallas
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

2.  Cancer incidence among Danish Seventh-day Adventists and Baptists.

Authors:  Lau Caspar Thygesen; Niels Christian Hvidt; Helle Ploug Hansen; Andreas Hoff; Lone Ross; Christoffer Johansen
Journal:  Cancer Epidemiol       Date:  2012-08-19       Impact factor: 2.984

3.  Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study.

Authors:  Chia-Hung Kao; Li-Min Sun; Ji-An Liang; Shih-Ni Chang; Fung-Chang Sung; Chih-Hsin Muo
Journal:  Mayo Clin Proc       Date:  2012-05       Impact factor: 7.616

4.  Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan.

Authors:  Chia-Hung Kao; Li-Min Sun; Kuan-Pin Su; Shih-Ni Chang; Fung-Chang Sung; Chih-Hsin Muo; Ji-An Liang
Journal:  J Clin Psychiatry       Date:  2012-04       Impact factor: 4.384

5.  Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-11-14       Impact factor: 17.586

6.  Cohort study of the association of hypnotic use with mortality in postmenopausal women.

Authors:  Arthur Hartz; John Jacob Ross
Journal:  BMJ Open       Date:  2012-09-12       Impact factor: 2.692

7.  2. Tobacco-attributable cancer burden in the UK in 2010.

Authors:  D M Parkin
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

8.  Hypnotics' association with mortality or cancer: a matched cohort study.

Authors:  Daniel F Kripke; Robert D Langer; Lawrence E Kline
Journal:  BMJ Open       Date:  2012-02-27       Impact factor: 2.692

  8 in total
  6 in total

1.  Reply to ‘Evidence for harm, comment on . . .’ by Kripke & Langer.

Authors:  Anton Pottegård; Søren Friis; Morten Andersen; Jesper Hallas
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

2.  External adjustment of unmeasured confounders in a case-control study of benzodiazepine use and cancer risk.

Authors:  Lau Caspar Thygesen; Anton Pottegård; Annette Kjaer Ersbøll; Søren Friis; Til Stürmer; Jesper Hallas
Journal:  Br J Clin Pharmacol       Date:  2017-07-12       Impact factor: 4.335

Review 3.  Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

Authors:  Daniel F Kripke
Journal:  F1000Res       Date:  2016-05-19

4.  Is long-term use of benzodiazepine a risk for cancer?

Authors:  Usman Iqbal; Phung-Anh Nguyen; Shabbir Syed-Abdul; Hsuan-Chia Yang; Chih-Wei Huang; Wen-Shan Jian; Min-Huei Hsu; Yun Yen; Yu-Chuan Jack Li
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

Review 5.  Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians.

Authors:  Gregory M Asnis; Manju Thomas; Margaret A Henderson
Journal:  Int J Mol Sci       Date:  2015-12-30       Impact factor: 5.923

6.  Is suvorexant a better choice than alternative hypnotics?

Authors:  Daniel F Kripke
Journal:  F1000Res       Date:  2015-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.